---
document_datetime: 2023-09-21 18:14:25
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/dasselta-epar-all-authorised-presentations_en.pdf
document_name: dasselta-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.3099301
conversion_datetime: 2025-12-21 17:01:51.916223
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU Number       | Name     | Strength   | Pharmaceutical Form   | Route of Administration   | Packaging                | Package size   |
|-----------------|----------|------------|-----------------------|---------------------------|--------------------------|----------------|
| EU/1/11/739/001 | Dasselta | 5 mg       | Film-coated tablet    | Oral use                  | blister (OPA/Al/PVC//Al) | 7 tablets      |
| EU/1/11/739/002 | Dasselta | 5 mg       | Film-coated tablet    | Oral use                  | blister (OPA/Al/PVC//Al) | 10 tablets     |
| EU/1/11/739/003 | Dasselta | 5 mg       | Film-coated tablet    | Oral use                  | blister (OPA/Al/PVC//Al) | 20 tablets     |
| EU/1/11/739/004 | Dasselta | 5 mg       | Film-coated tablet    | Oral use                  | blister (OPA/Al/PVC//Al) | 30 tablets     |
| EU/1/11/739/005 | Dasselta | 5 mg       | Film-coated tablet    | Oral use                  | blister (OPA/Al/PVC//Al) | 50 tablets     |
| EU/1/11/739/006 | Dasselta | 5 mg       | Film-coated tablet    | Oral use                  | blister (OPA/Al/PVC//Al) | 90 tablets     |
| EU/1/11/739/007 | Dasselta | 5 mg       | Film-coated tablet    | Oral use                  | blister (OPA/Al/PVC//Al) | 100 tablets    |
| EU/1/11/739/008 | Dasselta | 5 mg       | Film-coated tablet    | Oral use                  | bottle (HDPE)            | 250 tablets    |